Table 1 Baseline characteristics of patients stratified by four BMI categories.

From: Evaluating the obesity paradox in patients with sepsis and cancer

 

Underweight

Normal

Overweight

Obesity

p

n

173

1283

1498

960

 

Age

64.0 [56.0,75.0]

68.0 [59.0,77.5]

70.0 [60.0,79.0]

66.5 [59.0,75.0]

<0.001

Male

87 (50.3)

741 (57.8)

979 (65.4)

552 (57.5)

<0.001

Race

    

0.005

 White

106 (61.3)

920 (71.7)

1090 (72.8)

695 (72.4)

 

 Black

17 (9.8)

105 (8.2)

123 (8.2)

101 (10.5)

 

 Others

50 (28.9)

258 (20.1)

285 (19.0)

164 (17.1)

 

Admission category

     

 Elective

17 (9.8)

147 (11.5)

196 (13.1)

148 (15.4)

0.001

 Emergency

125 (72.3)

968 (75.4)

1156 (77.2)

699 (72.8)

 

 Others

31 (17.9)

168 (13.1)

146 (9.7)

113 (11.8)

 

Cancer site

    

<0.001

 Bladder

5 (2.9)

26 (2.0)

38 (2.5)

21 (2.2)

 

 Brain, central nervous system

5 (2.9)

34 (2.7)

64 (4.3)

33 (3.4)

 

 Breast

0(0)

27 (2.1)

33 (2.2)

25 (2.6)

 

 Cervix uteri

1 (0.6)

1 (0.1)

2 (0.1)

2 (0.2)

 

 Colorectum

6 (3.5)

51 (4.0)

54 (3.6)

35 (3.6)

 

 Corpus uteri

0(0)

2 (0.2)

3 (0.2)

15 (1.6)

 

 Esophagus

7 (4.0)

33 (2.6)

36 (2.4)

14 (1.5)

 

 Kidney

4 (2.3)

33 (2.6)

37 (2.5)

25 (2.6)

 

 Larynx

2 (1.2)

8 (0.6)

6 (0.4)

4 (0.4)

 

 Leukemia

11 (6.4)

96 (7.5)

134 (8.9)

80 (8.3)

 

 Lip, oral cavity

3 (1.7)

18 (1.4)

5 (0.3)

12 (1.2)

 

 Liver

3 (1.7)

96 (7.5)

106 (7.1)

80 (8.3)

 

 Lung

47 (27.2)

228 (17.8)

198 (13.2)

139 (14.5)

 

 Melanoma of skin

1 (0.6)

5 (0.4)

12 (0.8)

10 (1.0)

 

 Non-Hodgkin lymphoma

11 (6.4)

83 (6.5)

127 (8.5)

78 (8.1)

 

 Ovary

1 (0.6)

25 (1.9)

15 (1.0)

13 (1.4)

 

 Pancreas

17 (9.8)

96 (7.5)

96 (6.4)

43 (4.5)

 

 Prostate

4 (2.3)

48 (3.7)

75 (5.0)

54 (5.6)

 

 Stomach

7 (4.0)

18 (1.4)

45 (3.0)

16 (1.7)

 

 Thyroid

1 (0.6)

2 (0.2)

6 (0.4)

6 (0.6)

 

 Others

37 (21.4)

353 (27.5)

406 (27.1)

255 (26.6)

 

SOFA

3.0 [2.0,4.0]

3.0 [2.0,4.0]

3.0 [2.0,4.0]

3.0 [2.0,4.0]

0.011

SAPSII

43.0 [36.0,53.0]

44.0 [37.0,55.0]

45.0 [36.0,55.0]

44.0 [36.0,53.0]

0.416

GCS

15.0 [15.0,15.0]

15.0 [15.0,15.0]

15.0 [15.0,15.0]

15.0 [15.0,15.0]

0.051

Elixhauser comorbidities

5.0 [3.0,6.0]

5.0 [3.0,6.0]

5.0 [3.0,7.0]

6.0 [4.0,7.0]

<0.001

Diabetes

23 (13.3)

250 (19.5)

420 (28.0)

374 (39.0)

<0.001

Hypertension

60 (34.7)

455 (35.5)

644 (43.0)

443 (46.1)

<0.001

Time to antimicrobial therapy (h)

1.0 [0.0,9.0]

1.0 [0.0,6.0]

1.0 [0.0,7.0]

1.0 [0.0,7.0]

0.326

Laboratory tests

 Lactate (mmol/L)

1.7 [1.3,2.2]

1.8 [1.4,2.4]

1.9 [1.4,2.5]

1.9 [1.4,2.6]

0.018

 WBC (*109/L)

10.8 [6.7,15.4]

11.3 [7.0,16.6]

11.3 [7.1,16.2]

11.1 [7.5,15.9]

0.884

 Monocyte (*109/L)

0.5 [0.3,0.7]

0.5 [0.3,0.8]

0.5 [0.3,0.7]

0.5 [0.4,0.8]

0.776

 Neutrophil (*109/L)

9.6 [5.7,12.8]

9.4 [6.0,13.5]

9.1 [5.9,12.7]

9.3 [6.1,12.9]

0.5

 Lymphocyte (*109/L)

0.9 [0.6,1.2]

0.9 [0.6,1.2]

0.9 [0.6,1.3]

0.9 [0.7,1.3]

<0.001

 NLR

14.1 [9.3,18.6]

14.0 [8.3,20.5]

13.1 [7.8,19.1]

13.0 [7.5,19.3]

0.077

 ALT (IU/L)

39.0 [19.0,80.4]

44.0 [21.0,91.3]

48.9 [23.0,94.9]

48.8 [21.0,104.1]

0.021

 AST (IU/L)

50.0 [27.5,128.0]

62.0 [31.8,153.9]

65.4 [32.5,170.0]

66.2 [30.0,195.3]

0.022

 Total bilirubin (mg/dL)

0.9 [0.5,1.9]

1.1 [0.6,2.2]

1.2 [0.6,2.2]

1.1 [0.6,2.0]

0.008

 BUN (mg/dL)

20.0 [12.0,31.0]

21.0 [13.5,34.0]

23.0 [15.5,37.0]

25.0 [16.5,39.0]

<0.001

 Creatinine (mg/dL)

0.8 [0.6,1.3]

0.9 [0.7,1.4]

1.1 [0.8,1.6]

1.2 [0.8,1.8]

<0.001

 PO2 (mmHg)

99.5 [61.0,142.0]

91.5 [63.9,132.0]

98.2 [70.5,143.0]

96.5 [70.5,141.0]

0.001

 SpO2 (%)

98.0 [96.0,99.5]

97.0 [95.5,99.0]

97.0 [95.5,98.0]

97.0 [95.0,98.0]

<0.001

 INR

1.3 [1.2,1.5]

1.4 [1.2,1.6]

1.3 [1.2,1.6]

1.3 [1.2,1.6]

0.339

 Platelet (*109/L)

191.0 [119.0,306.0]

186.5 [109.5,277.8]

172.0 [108.0,252.9]

181.2 [109.0,253.2]

0.01

 Glucose (mg/dL)

114.0 [99.0,140.0]

123.5 [104.0,149.0]

130.0 [109.5,158.0]

139.0 [116.0,173.0]

<0.001

 Sodium (mEq/L)

138.0 [135.0,141.0]

137.0 [134.0,140.0]

137.0 [134.5,140.0]

137.5 [135.0,140.0]

0.005

 Chloride (mEq/L)

104.0 [100.0,109.0]

103.5 [100.0,107.0]

104.0 [100.0,107.0]

103.0 [99.5,107.0]

0.009

 Bicarbonate (mEq/L)

23.0 [20.5,26.0]

22.5 [19.5,25.0]

22.5 [19.5,25.0]

23.0 [20.0,26.0]

0.01

 Albumin (g/dL)

2.8 [2.6,3.1]

2.8 [2.6,3.1]

2.9 [2.6,3.1]

2.9 [2.7,3.2]

<0.001

Vital signs

 Heart rate (bpm)

90.5 [78.5,102.0]

89.0 [77.5,102.0]

88.0 [77.0,101.0]

88.0 [76.0,100.1]

0.292

 Respiratory rate (bpm)

19.0 [17.0,22.0]

20.0 [17.0,23.0]

19.8 [17.0,23.0]

20.0 [17.0,23.0]

0.506

 SBP (mmHg)

108.0 [100.0,119.0]

108.0 [100.0,118.0]

112.0 [102.5,123.0]

113.0 [103.0,124.0]

<0.001

 Temperature (°C)

36.8 [36.6,37.0]

36.8 [36.6,37.1]

36.8 [36.6,37.1]

36.8 [36.6,37.2]

0.007

  1. Data are N (%) or median [interquartile range].
  2. SOFA sequential organ failure assessment score, GCS glasgow coma scale score, WBC white blood cell count, NLR neutrophil-to-lymphocyte ratio, ALT alanine aminotransferase, AST aspartate aminotransferase, BUN blood urea nitrogen, PO2 partial pressure of oxygen, SpO2 peripheral capillary oxygen saturation, INR international normalized ratio, LOS length of stay in ICU, CRRT continuous renal replacement therapy, SBP systolic blood pressure.